The role of HTS in drug discovery at the University of Michigan

Comb Chem High Throughput Screen. 2014 Mar;17(3):210-30. doi: 10.2174/1386207317666140109121546.

Abstract

High throughput screening (HTS) is an integral part of a highly collaborative approach to drug discovery at the University of Michigan. The HTS lab is one of four core centers that provide services to identify, produce, screen and follow-up on biomedical targets for faculty. Key features of this system are: protein cloning and purification, protein crystallography, small molecule and siRNA HTS, medicinal chemistry and pharmacokinetics. Therapeutic areas that have been targeted include anti-bacterial, metabolic, neurodegenerative, cardiovascular, anti-cancer and anti-viral. The centers work in a coordinated, interactive environment to affordably provide academic investigators with the technology, informatics and expertise necessary for successful drug discovery. This review provides an overview of these centers at the University of Michigan, along with case examples of successful collaborations with faculty.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biological Products / chemistry
  • Biological Products / pharmacology
  • Chemistry, Pharmaceutical
  • Drug Discovery / methods*
  • Drug Discovery / organization & administration
  • Genomics / methods
  • High-Throughput Screening Assays / methods*
  • Humans
  • Michigan
  • Molecular Biology / methods
  • Molecular Biology / organization & administration
  • Pharmacokinetics
  • Protein Folding
  • Proteins / chemistry
  • Proteins / isolation & purification
  • Small Molecule Libraries / pharmacology
  • Universities / organization & administration*

Substances

  • Biological Products
  • Proteins
  • Small Molecule Libraries